B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 122-126

  Beland, Janice L ^a   Sobel, Raymond A ^b   Adler, Heiko ^a   Del Pan, Nadia C ^a   Rimm, Ilonna J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Palo Alto Vet Aff Hlth Care S   (United States)

Author keywords

B cell deficient mice; Encephalomyelitis; HSV 1

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENCEPHALOMYELITIS; HERPES SIMPLEX VIRUS 1; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION RISK; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033081135     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00238-0     Document Type: Article

References (23)

1. Adler H., Beland J.L., Del-Pan N.C., Kobzik L., Brewer J.P., Martin T.R., Rimm I.J. Suppression of Herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 185:1997;1533-1540.
2. Arrunategui-Correa V., Dutt J., Foster C.S. The role of B lymphocytes in experimental Herpes Simplex retinitis. Scand. J. Immunol. 40:1994;299-307.
3. Asano M.S., Ahmed R. CD8 T cell memory in B cell-deficient mice. J. Exp. Med. 183:1996;2165-2174.
4. Beutner U., Kraus E., Kitamura D., Rajewsky K., Huber B. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1994;1457-1466.
5. Bründler M., Aichele P., Bachmann M., Kitamura D., Rajewsky K., Zinkernagel R.M. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur. J. Immunol. 26:1996;2257-2262.
6. Hughes R.G., Munyon W.H. Temperature-sensitive mutants of Herpes Simplex Virus Type 1 defective in lysis but not in transformation. J. Virol. 16:1975;275-283.
7. Kapoor A.K., Nash A.A., Wildy P. Pathogenesis of Herpes Simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 61:1982;127-131.
8. Kitamura D., Roes J., Kühn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 350:1991;423-426.
9. Kohl S., Strynadka N.C.J., Hodges R.S., Pereira L. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J. Clin. Invest. 86:1990;273-278.
10. Kurtz C.I., Sun X.M., Fujinami R.S. B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J. Virol. 69:1995;5152-5155.
11. Larsen H.S., Russel R.G., Rouse B.T. Recovery from lethal herpes simplex virus type I infection is mediated by cytotoxic T lymphocytes. Infection and Immunity. 41:1983;197-204.
12. Lawton A.R.I., Asofsky R., Hylton M.B., Cooper M.D. Suppression of immunoglobulin class synthesis in mice. J. Exp. Med. 135:1972;277-297.
13. McKendall R., Klassen T., Baringer J.R. Host defenses in Herpes Simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect. Immun. 23:1979;305-311.
14. Mester J.C., Rouse B.T. The mouse model and understanding immunity to herpes simplex virus. Rev. Infect. Dis. 13:1991;S935-945.
15. Mitchell B.M., Stevens J.G. Neuroinvasive properties of herpes simplex virus type I glycoprotein variants are controlled by the immune response. J. Immunol. 156:1996;246-255.
16. Mokhtarian F., Wesselingh S.L., Choi S., Griffin D.E., Sobel R.A., Grob D. Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. J. Neuroimmunol. 66:1996;11-22.
17. Openshaw H., Asher L., Wohlenberg C., Sekizawa T., Notkins A.L. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J. Gen. Virol. 44:1979;205-215.
18. Sasaki H., Schmitt D.A., Matsumoto K., Pollard R., Suzuki F. Demonstration of a B cell population that regulates the immune response in spleens of mice infected with Herpes Simplex virus Type I. Clin. Immunol. Immunopathol. 66:1993;169-175.
19. Schultz K.R., Klarnet J.P., Randall S.G., HayGlass K.T., Greenberg P.D. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science. 249:1990;921-923.
20. Sciammas R., Kodukula P., Tang Q., Hendricks R.L., Bluestone J.A. T cell receptor gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 185:1997;969-1175.
21. Simmons A., Nash A.A. Effect of B cell suppression on primary infection and reinfection of mice with Herpes Simplex virus. J. Infect. Dis. 155:1987;649-654.
22. Stevens J.G. HSV-1 neuroinvasiveness. Intervirology. 35:1993;152-163.
23. Thomsen A.R., Johansen J., Marker O., Christensen J.P. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC Class II-deficient mice and B cell-deficient mice. J. Immunol. 157:1996;3074-3080.